Breast implants are facing renewed scrutiny following past scandals like the 2010 PIP affair, which exposed questionable practices in the industry. Now, health authorities have identified a link to a rare but serious cancer.
A specific type of cancer
Investigations by Le Parisien revealed that breast implants are associated not with breast cancer, but with anaplastic large cell lymphoma (ALCL), a rare tumor. Over three years, France reported 18 cases out of 173 worldwide, with numbers rising steadily. Tragically, one patient has died from the disease, prompting global concerns and urgent research into the causes.
Implant surface triggers inflammation
All affected patients share one factor: breast implants. Evidence points not to the implant filling but to chronic inflammation around the prosthesis surface as the likely culprit.
Is Allergan at fault?
Of France's 18 cases reported to the National Medicines Safety Agency (ANSM), 14 involved Allergan implants. This raises questions, though Le Parisien notes no clear explanation yet. Allergan maintains full transparency and denies wrongdoing. Prior inspections in 2012 and 2013 found no issues, but new reviews are underway to assess any role or coincidence. No brand has been officially implicated.
Annual medical check-ups are essential
Nearly 400,000 French women have breast implants—80% for cosmetic reasons, the rest for reconstruction after breast cancer. Yet many lack proper follow-up. Experts strongly recommend annual exams by a healthcare professional, a guideline often overlooked.
A low but real risk
Prospective patients must be informed of this emerging risk, however small. Information leaflets have been distributed to healthcare providers for patient education.
A potential ban on the horizon?
In ten days, the ANSM will convene a key meeting. Some push for better tracking of medical devices, while others favor an outright ban. The ANSM director states that if experts vote for prohibition, it can be enacted swiftly.
